
Wegovy pill hits 3 million US prescriptions since January, showing strong demand for weight-loss drugs
The Wegovy pill, a GLP-1 weight-loss medication by Novo Nordisk, has surpassed 3 million prescriptions in the US since its launch on January 5, 2026. This equates to one prescription filled every five seconds, marking it as one of the most successful...

